MSD’s HPV vaccine gains China NMPA’s expanded approval for males
China's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.
China's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.
What's Your Reaction?
